Page 7 - Check Cap News Today

Check-Cap (NASDAQ:CHEK – Get Rating) posted its earnings results on Wednesday. The medical research company reported ($0.06) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.01), MarketWatch Earnings reports. Check-Cap stock opened at $0.36 on Thursday. The company has a market capitalization of $35.08 million, a P/E ratio of -1.73 […]

Zacks Investment Research downgraded shares of Check-Cap (NASDAQ:CHEK – Get Rating) from a buy rating to a hold rating in a research note released on Thursday, Zacks.com reports. According to Zacks, “Check Cap Ltd. is a medical diagnostics company. The company is engaged in the development of an ingestible imaging capsule for the screening of […]

Check-Cap (NASDAQ:CHEK – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Monday, Zacks.com reports. The brokerage presently has a $0.50 price target on the medical research company’s stock. Zacks Investment Research‘s price target would indicate a potential upside of 30.34% from the […]

Wall Street brokerages predict that Check-Cap Ltd. (NASDAQ:CHEK – Get Rating) will post earnings per share of ($0.03) for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Check-Cap’s earnings, with the lowest EPS estimate coming in at ($0.04) and the highest estimate coming in at ($0.02). Check-Cap reported earnings of […]

Share this article Share this article ISFIYA, Israel, Jan. 27, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan ®, the first and only patient-friendly preparation-free screening test to detect polyps before they may transform into colorectal cancer, today issued the following letter from its chief executive officer, Alex Ovadia to its shareholders and the inv...

Smart Pills Market Size To Grow USD 650 million, Globally, By 2025 Pune, Maharashtra, India, December 16 2020 (Wiredrelease) Allied Analytics –:UPDATE AVAILABLE ON-DEMAND The report on the global smart pills market highlights that the market is expected to reach $257 million in 2017, and is projected to reach $650 million by 2025, growing at a CAGR of 12.1% from 2018 to 2025. The report offers the current market size and forecasts along with Porter’s Five Forces anal...